AMGEN Inc
NASDAQ: AMGN
$270.77
-$23.23 (-7.9%)
Real Time Data Delayed 15 Min.
AMGN Articles
These are some of this Friday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Raised to Outperform at Leerink Swann. AON...
Published:
Last Updated:
The Battelle Memorial Institute, which looks at R&D in major nations, says that China will pass Japan as the No.2 spender next year. “China is expected to spend $153.7 billion on R&D in...
Published:
Last Updated:
These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Raised to Overweight at Piper Jaffray. AT&T Inc....
Published:
Last Updated:
These are some of this Tuesday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Started as Neutral at Credit Suisse. AstraZeneca...
Published:
Last Updated:
Biotech and emerging pharma both seem to have almost no friends today despite a large stock market rally. It may take a resolution of the Genzyme Corporation (NASDAQ: GENZ) merger, and a successful...
Published:
Earnings season is in full swing and the peak will occur next week. We have several DJIA components reporting earnings along with several other companies which are equally as important to the...
Published:
Last Updated:
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months. The news is not even on any of the...
Published:
Last Updated:
These are some of this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Amgen Inc. (NASDAQ: AMGN) Started as Buy at Stifel Nicolaus. AngloGold...
Published:
Last Updated:
Genzyme Corporation (NASDAQ: GENZ) still has an incredible merger ‘deal premium’ associated with it over a pending Sanofi-Aventis (NYSE: SNY) buyout. Genzyme’s troubles have left it...
Published:
Last Updated:
Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the company. The WSJ reports that the large drug giant has approached...
Published:
Last Updated:
Today’s version of the BioHealth Business Daily is a very unusual lot of movers. Some moves are merely in sympathy and some are on news. We also have a re-review of Amgen Inc. (NASDAQ: AMGN)...
Published:
Last Updated:
Sanofi-Aventis SA (NYSE: SNY) was a bit of a stalking horse news item on a week that many investors and traders started taking off for a long weekend. The company has tried to telegraph the...
Published:
Last Updated:
There are many key movers in today’s BioHealth Business Daily. We have included background data, news, reactions, and added in color where applicable. BioHealth stocks to watch today are Amgen...
Published:
Last Updated:
Biotech is the land of promise for emerging players. It is also the land of stagnation for well established and sturdy giants. Amgen, Inc. (NASDAQ: AMGN), Biogen Idec Inc. (NASDAQ: BIIB), and...
Published:
Last Updated:
It looks as though none of this morning’s major day trader and active trader alerts are on raw earnings announcements. On the move are shares of American International Group Inc. (NYSE: AIG),...
Published:
Last Updated: